137 related articles for article (PubMed ID: 29146542)
1. Development of a mucoadhesive delivery system for control release of doxepin with application in vaginal pain relief associated with gynecological surgery.
Sanz R; Clares B; Mallandrich M; Suñer-Carbó J; Montes MJ; Calpena AC
Int J Pharm; 2018 Jan; 535(1-2):393-401. PubMed ID: 29146542
[TBL] [Abstract][Full Text] [Related]
2. Development of a buccal doxepin platform for pain in oral mucositis derived from head and neck cancer treatment.
Sanz R; Calpena AC; Mallandrich M; Gimeno Á; Halbaut L; Clares B
Eur J Pharm Biopharm; 2017 Aug; 117():203-211. PubMed ID: 28438551
[TBL] [Abstract][Full Text] [Related]
3. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive In Situ Gelling Liquid Crystalline Precursor System to Improve the Vaginal Administration of Drugs.
de Araújo PR; Calixto GMF; da Silva IC; de Paula Zago LH; Oshiro Junior JA; Pavan FR; Ribeiro AO; Fontana CR; Chorilli M
AAPS PharmSciTech; 2019 Jun; 20(6):225. PubMed ID: 31214798
[TBL] [Abstract][Full Text] [Related]
5. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels.
Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512
[TBL] [Abstract][Full Text] [Related]
6. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Karimunnisa S; Atmaram P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
[TBL] [Abstract][Full Text] [Related]
8. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
Perioli L; Ambrogi V; Venezia L; Giovagnoli S; Pagano C; Rossi C
Drug Dev Ind Pharm; 2009 Jul; 35(7):769-79. PubMed ID: 19337872
[TBL] [Abstract][Full Text] [Related]
9. Vaginal Delivery of Benzydamine Hydrochloride through Liposomes Dispersed in Mucoadhesive Gels.
Tuğcu-Demiröz F
Chem Pharm Bull (Tokyo); 2017 Jul; 65(7):660-667. PubMed ID: 28442642
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive in situ forming gel for oral mucositis pain control.
Li T; Bao Q; Shen J; Lalla RV; Burgess DJ
Int J Pharm; 2020 Apr; 580():119238. PubMed ID: 32194210
[TBL] [Abstract][Full Text] [Related]
11. Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms.
Bonferoni MC; Giunchedi P; Scalia S; Rossi S; Sandri G; Caramella C
AAPS PharmSciTech; 2006; 7(4):104. PubMed ID: 17285750
[TBL] [Abstract][Full Text] [Related]
12. Bioadhesive emulsions for control release of progesterone resistant to vaginal fluids clearance.
Campaña-Seoane M; Peleteiro A; Laguna R; Otero-Espinar FJ
Int J Pharm; 2014 Dec; 477(1-2):495-505. PubMed ID: 25445529
[TBL] [Abstract][Full Text] [Related]
13. S-protected gellan gum: Decisive approach towards mucoadhesive antimicrobial vaginal films.
Jalil A; Asim MH; Le NN; Laffleur F; Matuszczak B; Tribus M; Bernkop-Schnürch A
Int J Biol Macromol; 2019 Jun; 130():148-157. PubMed ID: 30779984
[TBL] [Abstract][Full Text] [Related]
14. Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids.
Aka-Any-Grah A; Bouchemal K; Koffi A; Agnely F; Zhang M; Djabourov M; Ponchel G
Eur J Pharm Biopharm; 2010 Oct; 76(2):296-303. PubMed ID: 20656027
[TBL] [Abstract][Full Text] [Related]
15. Vaginal mucoadhesive drug delivery systems.
de Araújo Pereira RR; Bruschi ML
Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.
Hombach J; Palmberger TF; Bernkop-Schnürch A
J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796
[TBL] [Abstract][Full Text] [Related]
17. Transbuccal delivery of doxepin: studies on permeation and histological investigation.
Gimeno A; Calpena AC; Sanz R; Mallandrich M; Peraire C; Clares B
Int J Pharm; 2014 Dec; 477(1-2):650-4. PubMed ID: 25445535
[TBL] [Abstract][Full Text] [Related]
18. A novel double-layer mucoadhesive tablet containing probiotic strain for vaginal administration: Design, development and technological evaluation.
Sánchez MT; Ruiz MA; Castán H; Morales ME
Eur J Pharm Sci; 2018 Jan; 112():63-70. PubMed ID: 29129498
[TBL] [Abstract][Full Text] [Related]
19. Modified biomolecule as potential vehicle for buccal delivery of doxepin.
Laffleur F; Zilio M; Shuwisitkul D
Ther Deliv; 2016 Oct; 7(10):683-689. PubMed ID: 27790954
[TBL] [Abstract][Full Text] [Related]
20. Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters.
das Neves J; Amaral MH; Bahia MF
Eur J Pharm Biopharm; 2008 Jun; 69(2):622-32. PubMed ID: 18248972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
